Molecular Targets and Therapeutic Interventions against Neurodegenerative Diseases (Record no. 8559)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02297 a2200361 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1040309984 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250328151426.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250324022025xx 138 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781040309988 |
| Qualifying information | EA |
| 037 ## - SOURCE OF ACQUISITION | |
| Source of stock number/acquisition | Taylor & Francis |
| Terms of availability | GBP 49.99 |
| Form of issue | BB |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | 01 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PSAN |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBGR |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TBN |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PSAN |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBGR |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TBN |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | SCI089000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED071000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | SCI050000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | 616.8 |
| Source | bisac |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Vaishali Manikrao Patil |
| 245 10 - TITLE STATEMENT | |
| Title | Molecular Targets and Therapeutic Interventions against Neurodegenerative Diseases |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | CRC Press |
| Date of publication, distribution, etc. | 20250331 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 300 p |
| 520 ## - SUMMARY, ETC. | |
| Expansion of summary note | This book comprehensively explores the latest advancements in the understanding, diagnosis, and treatment of neurodegenerative diseases. The chapters provide an in-depth review of current approaches and treatment strategies for Alzheimer's disease, offering insights into the latest developments and breakthroughs. It also reviews the cutting-edge research on potential novel targets for Alzheimer's pharmacotherapy, with a focus on JNK3, GSK3β, and Fyn kinase inhibitors, providing an update on related approaches and their implications. It discusses the potential of ethnomedicines as a promising tool for mitigating Alzheimer's disease, offering insights into traditional remedies and their modern applications. Additional chapters explore the influence of microglia, the neuropharmacological mechanisms associated with SARS-CoV-2, and the molecular intricacies of Parkinson’s disease. The book further covers the evolving role of artificial intelligence and machine learning in the management of neurodegenerative disorders. The chapters also examine the role of nanotechnology in addressing the challenges of diseases like multiple sclerosis. Towards the end, the book examines the role of oxidative damage in neurodegeneration and its management in related disorders. This book is an important source for neuroscientists, neurologists, and students of neuroscience. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dileep Kumar |
| Relationship | B01 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | NEERAJ MASAND |
| Relationship | B01 |
No items available.